Back to School: How biopharma can reboot drug development. Access exclusive analysis here

: Phase Ib

Sarawak reported data from two Phase Ib studies of (+)-calanolide A monotherapy in a total

Read the full 157 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE